Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A08002 | 32283070 | Chem Biol Interact | Role of epidermal growth factor receptor in liver injury and lipid metabolism: Emerging new roles for an old receptor. | 2020 | Details |
| A08004 | 32282030 | Br Med Bull | Obeticholic acid-a new therapy in PBC and NASH. | 2020 | Details |
| A08008 | 32281248 | Liver Int | Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinoma. | 2020 | Details |
| A08009 | 32280969 | Clin Infect Dis | Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus. | 2020 | Details |
| A08010 | 32280772 | JGH Open | Screening for non-alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter-transient elastography. | 2019 | Details |
| A08030 | 32275982 | J Hepatol | Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis. | 2020 | Details |
| A08032 | 32275114 | FASEB J | Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis. | 2020 | Details |
| A08042 | 32272251 | Clin Gastroenterol Hepatol | Diagnostic Performance of Vibration-Controlled Transient Elastography in Liver Transplant Recipients. | 2020 | Details |
| A08044 | 32271385 | J Clin Endocrinol Metab | Plasma BCAA Changes in Patients With NAFLD Are Sex Dependent. | 2020 | Details |
| A08045 | 32270862 | Clin Infect Dis | Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A08048 | 32268517 | J Clin Med | Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience. | 2020 | Details |
| A08049 | 32268264 | Nutrition | Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH. | 2020 | Details |
| A08053 | 32267638 | Ned Tijdschr Geneeskd | [Non-alcoholic fatty liver disease; a full-bodied epidemic]. | 2020 | Details |
| A08063 | 32259482 | Cell Metab | Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis. | 2020 | Details |
| A08064 | 32258947 | Hepatol Commun | Nonalcoholic Fatty Liver Disease: Interface Between Primary Care and Hepatology Clinics. | 2020 | Details |
| A08066 | 32258944 | Hepatol Commun | Pathogenesis of Nonalcoholic Steatohepatitis: An Overview. | 2020 | Details |
| A08067 | 32258535 | Transl Gastroenterol Hepatol | Non-invasive diagnosis: non-alcoholic fatty liver disease and alcoholic liver disease. | 2020 | Details |
| A08068 | 32258528 | Transl Gastroenterol Hepatol | Nonalcoholic steatohepatitis recurrence after liver transplant. | 2020 | Details |
| A08071 | 32258520 | Transl Gastroenterol Hepatol | Epidemiology of non-alcoholic and alcoholic fatty liver diseases. | 2020 | Details |
| A08072 | 32258441 | Biochem Biophys Rep | Differentially expressed mRNAs and lncRNAs shared between activated human hepatic stellate cells and nash fibrosis. | 2020 | Details |
| A08074 | 32257903 | Lab Anim Res | Comparative study of liver injury induced by high-fat methionine- and choline-deficient diet in ICR mice originating from three different sources. | 2019 | Details |
| A08077 | 32256346 | Front Pharmacol | Hepatoprotective Effect of Cranberry Nutraceutical Extract in Non-alcoholic Fatty Liver Model in Rats: Impact on Insulin Resistance and Nrf-2 Expression. | 2020 | Details |
| A08084 | 32253274 | J Am Soc Nephrol | Fructose Production and Metabolism in the Kidney. | 2020 | Details |
| A08085 | 32253259 | Gut | LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover. | 2020 | Details |
| A08086 | 32252641 | BMC Gastroenterol | Magnetic resonance elastography in staging liver fibrosis in non-alcoholic fatty liver disease: a pooled analysis of the diagnostic accuracy. | 2020 | Details |
| A08087 | 32252638 | BMC Gastroenterol | Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. | 2020 | Details |
| A08089 | 32251945 | Bioorg Chem | Discovery of novel dual PPARα/δ agonists based on benzimidazole scaffold for the treatment of non-alcoholic fatty liver disease. | 2020 | Details |
| A08090 | 32251018 | Clin Transl Gastroenterol | Multiparametric MR Is a Valuable Modality for Evaluating Disease Severity of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08093 | 32249283 | J Infect Dis | Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection. | 2020 | Details |
| A08095 | 32247823 | J Hepatol | Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis. | 2020 | Details |
| A08096 | 32246926 | Exp Mol Pathol | Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in SHRSP5/Dmcr rat model. | 2020 | Details |
| A08097 | 32246876 | J Gastroenterol Hepatol | Development and validation of a novel non-invasive test for diagnosing fibrotic non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease. | 2020 | Details |
| A08110 | 32243868 | Metabolism | Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model. | 2020 | Details |
| A08111 | 32243703 | Liver Int | Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A08115 | 32241197 | Expert Rev Gastroenterol Hepatol | Obeticholic acid for the treatment of nonalcoholic steatohepatitis. | 2020 | Details |
| A08117 | 32240838 | Atherosclerosis | Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease. | 2020 | Details |
| A08119 | 32240652 | Biochem Pharmacol | Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: Insight on hedgehog/Gli and Wnt/β-catenin signaling crosstalk. | 2020 | Details |
| A08122 | 32239453 | Endocrine | Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a protective factor. | 2020 | Details |
| A08123 | 32239376 | Dig Dis Sci | Exercise Attenuates Ribosomal Protein Six Phosphorylation in Fatty Liver Disease. | 2020 | Details |
| A08128 | 32237916 | Expert Opin Pharmacother | Current and new pharmacotherapy options for non-alcoholic steatohepatitis. | 2020 | Details |
| A08130 | 32235829 | Cell Death Dis | TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice. | 2020 | Details |
| A08132 | 32235601 | J Clin Med | Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients. | 2020 | Details |
| A08135 | 32234329 | J Hepatol | Volixibat in adults with non-alcoholic steatohepatitis: 24-week interim analysis from a randomized, phase II study. | 2020 | Details |
| A08148 | 32228845 | Med Sci (Paris) | [Emergence of 3D human fatty liver models engineered in the laboratory]. | 2020 | Details |
| A08149 | 32228319 | Am J Physiol Endocrinol Metab | Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease. | 2020 | Details |
| A08154 | 32225165 | J Vis Exp | Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology. | 2020 | Details |
| A08155 | 32225108 | Int J Mol Sci | Targeting of Secretory Proteins as a Therapeutic Strategy for Treatment of Nonalcoholic Steatohepatitis (NASH). | 2020 | Details |
| A08162 | 32222944 | Indian J Gastroenterol | Correlation between insulin resistance and liver histology in patients with nonalcoholic steatohepatitis with and without obesity. | 2020 | Details |
| A08180 | 32217109 | Chem Biol Interact | Familial non-alcoholic steatohepatitis leading to hepatocellular carcinoma. | 2020 | Details |
| A08181 | 32217100 | Biochem Pharmacol | Modulation of SIRT1-mediated signaling cascades in the liver contributes to the amelioration of nonalcoholic steatohepatitis in high fat fed middle-aged LDL receptor knockout mice by dihydromyricetin. | 2020 | Details |
| A08190 | 32213023 | United European Gastroenterol J | Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis. | 2020 | Details |
| A08193 | 32211410 | Front Cell Dev Biol | Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases. | 2020 | Details |
| A08195 | 32210914 | Front Endocrinol (Lausanne) | The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08200 | 32207804 | JAMA | Nonalcoholic Steatohepatitis: A Review. | 2020 | Details |
| A08202 | 32207277 | Endocrinol Metab (Seoul) | Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis. | 2020 | Details |
| A08204 | 32207237 | Obes Rev | Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature. | 2020 | Details |
| A08206 | 32205419 | Gut | Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease. | 2020 | Details |
| A08210 | 32203743 | Atherosclerosis | Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor. | 2020 | Details |
| A08214 | 32200381 | Obes Facts | The Effect of Moderate Weight Loss on a Non-Invasive Biomarker of Liver Fibrosis: A Randomised Controlled Trial. | 2020 | Details |
| A08215 | 32200254 | Biomed Pharmacother | Hepalatide ameliorated progression of nonalcoholic steatohepatitis in mice. | 2020 | Details |
| A08218 | 32198617 | Obes Surg | Hepatic Function and Fibrosis Assessment Via 2D-Shear Wave Elastography and Related Biochemical Markers Pre- and Post-Gastric Bypass Surgery. | 2020 | Details |
| A08219 | 32196896 | Diabetes Obes Metab | Incretin combination therapy for the treatment of non-alcoholic steatohepatitis. | 2020 | Details |
| A08221 | 32195455 | JHEP Rep | Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease. | 2020 | Details |
| A08225 | 32193478 | Sci Rep | The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index. | 2020 | Details |
| A08231 | 32192216 | Int J Mol Sci | PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice. | 2020 | Details |
| A08245 | 32189926 | J Clin Exp Hepatol | Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment. | 2019 | Details |
| A08251 | 32188385 | Curr Vasc Pharmacol | Non-Alcoholic Fatty Liver Disease and Vascular Disease. | 2021 | Details |
| A08253 | 32187572 | Environ Int | Long-term environmental exposure to microcystins increases the risk of nonalcoholic fatty liver disease in humans: A combined fisher-based investigation and murine model study. | 2020 | Details |
| A08259 | 32184641 | Diabetes Metab Syndr Obes | Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study. | 2020 | Details |
| A08262 | 32184095 | Clin Chim Acta | COX-2 in liver fibrosis. | 2020 | Details |
| A08263 | 32183383 | Diagnostics (Basel) | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan. | 2020 | Details |
| A08265 | 32181573 | Liver Int | Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives. | 2020 | Details |
| A08266 | 32181157 | Front Oncol | Effect of Non-alcoholic Fatty Liver Disease on the Risk of Synchronous Liver Metastasis: Analysis of 451 Consecutive Patients of Newly Diagnosed Colorectal Cancer. | 2020 | Details |
| A08271 | 32176759 | J Gastrointestin Liver Dis | Association of Serum Homocysteine Levels with Histological Severity of NAFLD. | 2020 | Details |
| A08273 | 32175323 | Front Med (Lausanne) | Hepatic Autonomic Nervous System and Neurotrophic Factors Regulate the Pathogenesis and Progression of Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08276 | 32171530 | Biochem Biophys Res Commun | Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway. | 2020 | Details |
| A08277 | 32171275 | BMC Pediatr | Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017. | 2020 | Details |
| A08279 | 32170962 | Hepatology | Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology. | 2020 | Details |
| A08281 | 32170564 | Surg Endosc | Evaluation of the histological variability of core and wedge biopsies in nonalcoholic fatty liver disease in bariatric surgical patients. | 2020 | Details |
| A08282 | 32170127 | Sci Rep | Western diet induces severe nonalcoholic steatohepatitis, ductular reaction, and hepatic fibrosis in liver CGI-58 knockout mice. | 2020 | Details |
| A08284 | 32169461 | Clin Res Hepatol Gastroenterol | Gender differences in liver fibrosis among patients younger than 50 years: A retrospective cohort study. | 2020 | Details |
| A08288 | 32168769 | Int J Mol Sci | Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08290 | 32168345 | PLoS One | Characterization of the immune cell landscape of patients with NAFLD. | 2020 | Details |
| A08291 | 32168133 | J Clin Gastroenterol | Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A08293 | 32166191 | Health Sci Rep | Noninvasive diagnosis in alcohol-related liver disease. | 2020 | Details |
| A08301 | 32161197 | JCI Insight | Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease. | 2020 | Details |
| A08304 | 32160239 | PLoS One | Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs. | 2020 | Details |
| A08305 | 32158763 | Front Med (Lausanne) | Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice. | 2020 | Details |
| A08306 | 32158445 | Front Immunol | CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism. | 2020 | Details |
| A08311 | 32157523 | Obes Surg | Performance of Noninvasive Liver Fibrosis Scores in the Morbid Obese Patient, Same Scores but Different Thresholds. | 2020 | Details |
| A08314 | 32156227 | Curr Pharm Des | Modifiers of Liver-Related Manifestation in the Course of NAFLD. | 2020 | Details |
| A08316 | 32155178 | PLoS One | Gender differences in diet-induced steatotic disease in Cyp2b-null mice. | 2020 | Details |
| A08319 | 32153044 | J Gastroenterol Hepatol | Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels. | 2020 | Details |
| A08321 | 32152903 | Indian J Gastroenterol | Epidemiology of non-alcoholic fatty liver disease in Asia. | 2020 | Details |
| A08322 | 32152902 | Indian J Gastroenterol | Treatment of non-alcoholic fatty liver disease - Current perspectives. | 2020 | Details |
| A08323 | 32152677 | Surg Endosc | Impact of laparoscopic sleeve gastrectomy on fibrosis stage in patients with child-A NASH-related cirrhosis. | 2020 | Details |
| A08324 | 32152511 | Eur J Clin Nutr | Association of grip strength with non-alcoholic fatty liver disease: investigation of the roles of insulin resistance and inflammation as mediators. | 2020 | Details |
| A08326 | 32151955 | Int Immunopharmacol | Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways. | 2020 | Details |
| A08327 | 32151660 | Metabolism | Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis. | 2020 | Details |
| A08328 | 32151552 | Surg Obes Relat Dis | Management of nonalcoholic fatty liver disease and the role of bariatric surgery: a brief review for surgeons. | 2020 | Details |